Clostridium Difficile Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Evaluation of Fidaxomicin in the Treatment of Clostridium Difficile Infection (CDI)
Condition: Clostridium Difficile Infection (CDI) Intervention: Drug: Fidaxomicin Sponsors: University of Pittsburgh; Merck Sharp & Dohme Corp. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2019 Category: Research Source Type: clinical trials
